Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Prostate Cancer treatment details. Chemotherapy. University of Michigan, Ann Arbor MI, United States

Survival: 18.0 months
Toxicity Grade: 4
Treatments: Chemotherapy
Country: United States
City/State/Province: Ann Arbor MI
Hospital: University of Michigan
Journal: Link
Date: 12/2005

Patients: This study involved 42 men with chemotherapy-naive metastatic hormone-resistant prostate cancer. The median age was 73 years. None of the patients had received chemotherapy prior to this study.

Treatment: The treatment consisted of one chemotherapeutic agent: ixabepilone.

Toxicity: Grade 3-4 toxicities included neutropenia, leukopenia, neurologic toxicity, hematologic toxicity, flu-like symptoms, and infection.

Results: The median overall survival was 18 months.

Support: One of the authors had received research support from BMS. BMS manufactures and/or markets ixabepilone.

Correspondence: Maha Hussain

E-mail to a Friend Email Physician More Information